First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Mitchell
News Release
FDA Authorizes Second Coronavirus (SARS-CoV2) Vaccine for Use
On December 18, 2020, one week after authorizing the first SARS-CoV2 vaccine (Pfizer) for emergency use, the U.S.
Workers' Comp
Blog
Network 2.0 - Constructive partnerships between providers and payers
In our last blog post we discussed how networks help to manage the relationship with the provider and allow patients to sidest
Mitchell
News Release
Mitchell Predicts 2021 Trends in Its Fourth Quarter 2020 Industry Trends Report
SAN DIEGO, CA—Mitchell International, Inc., a leading provider of technology, connectivity and information solutions to the proper
Auto Physical Damage
Article
Current Used Vehicle Market Conditions: Q3 2020
September 2020 Kontos Kommentary
Mitchell
News Release
FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Emergency Use
On December 11, 2020, the
Workers' Comp
News Release
AvKARE Issues Voluntary Nationwide Recall of Certain Sildenafil and Trazodone Tablets
AvKARE, Inc., a subsidiary of Amneal Pharmaceuticals located in Pulaski, Tennessee,